Overview

Russian Kogenate Pediatric Study

Status:
Completed

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

A prospective study to evaluate the effect of rFVIII-FS in different prophylactic regimens on bleeding events frequency and development of arthropathy in Previously Treated and Minimally treated Hemophilia A pediatric population.

Phase:

Phase 4

Details

Lead Sponsor:

Bayer

Treatments:

Factor VIII